<DOC>
	<DOCNO>NCT02110849</DOCNO>
	<brief_summary>To prospectively collect data patient treat proton therapy prostate cancer use IUHPTC technique evaluation toxicity efficacy treatment technique .</brief_summary>
	<brief_title>Prostate Cancer Parameters Patients Receiving Proton Treatment</brief_title>
	<detailed_description>The major purpose study analyze side effect experience self-reported prostate cancer patient undergo proton radiation therapy IUHPTC . With information collect , investigator establish pre-existing condition proton treatment measure side effect treatment related pre-existing condition . Also , compare long-term side effect patient treat hormone suppression therapy along proton therapy patient get treat hormone suppression therapy . This information help doctor well understand side effect experience may help provide valuable information future patient make decision regard treatment option . Finally , develop database information regard treatment outcome patient prostate cancer order improve care patient type cancer .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Subjects must histologically cytologically confirm adenocarcinoma prostate schedule receive proton radiation treatment IUHPTC . Subjects stage grade tumor allow include proton salvage therapy context rise PSA surgery negative metastatic workup . Prior use Lupron therapy similar agent allow . Use Lupron similar agent must ≤ 6 month prior enrollment . Use Casodex agent drug class allow . Age ≥ 18 year time consent . The ability understand willingness sign inform consent authorization release health information . Evidence distant metastasis time enrollment .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Prostate</keyword>
	<keyword>Proton Therapy</keyword>
	<keyword>Cancer</keyword>
</DOC>